Livestream Registration | Today! Join the 2025 WAIC Qiming Venture Partners Entrepreneurship and Investment Forum — Venture Capital Enters a Resonance Cycle of AI Technology and Applications
This sub-forum will showcase and explore the latest breakthroughs in AI technology and applications through an innovation lens. Qiming Venture Partners will bring together top scholars and leading entrepreneurs in the field — from both the startup and investment perspectives — for four keynote speeches and four panel discussions.
World Artificial Intelligence Conference
Qiming Venture Partners · Entrepreneurship and Investment Forum
Venture Capital Unleashing the Resonance Cycle of AI Technology and Applications
Kicking Off Today!
This is a sub-forum that showcases and explores the latest breakthroughs in AI technology and applications through an innovation lens.
From the perspectives of entrepreneurship and investment, we join hands with leading scholars and visionary founders in the field to bring you:
- 4 keynote speeches
- 4 panel discussions
Where is the next stop in the evolution of large model technology?
Are world models the critical path to AGI?
When will Embodied Artificial Intelligence achieve large-scale commercial deployment?
Is AI hardware a blue ocean market for Chinese entrepreneurs?
Can startups break free from the "shadow of the giants"?
Which fields are nurturing the next wave of disruptive entrepreneurial opportunities?
This Morning at 9:00 AM
Registered attendees, please proceed to the venue:
Blue Hall, 4th Floor, Shanghai World Expo Center (Gate 2, No. 1500 Expo Avenue, Pudong New Area, Shanghai, China)
Please present your successful reservation e-ticket for pre-check at entry, and pass through the turnstile via facial recognition. (We recommend bringing your original ID card for verification.)
For those unable to attend in person, please follow the Qiming Venture Partners WeChat official account and reserve the livestream on Qiming Venture Partners' WeChat Channels.
You may also click "Read More" at the end of this article or scan the QR code below to watch the Chinese or English (with simultaneous interpretation subtitles) livestream of this forum on the official WAIC website.
Latest Full Agenda
Past Highlights
Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since its inception, the firm has focused on investing in outstanding early and growth-stage companies in Technology and Healthcare.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative enterprises. More than 210 of these have gone public on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. Over 80 portfolio companies have become recognized unicorns or super-unicorns.
Many Qiming Venture Partners portfolio companies have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), Insta360 (688775.SH), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), Sinocelltech (688520.SH), Yuanxin Technology, Insilico Medicine, MediLink Therapeutics, LaNova Medicines, Zhipu AI, StepFun, Biren Technology, and others.